Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-11-018135
Filing Date
2011-03-30
Accepted
2011-03-30 09:38:48
Documents
11
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 v216520_10k.htm 10-K 1498890
2 v216520_ex10-17.htm EX-10.17 6044
3 GRAPHIC ex10-17pg01.jpg GRAPHIC 103589
4 GRAPHIC ex10-17pg02.jpg GRAPHIC 100916
5 GRAPHIC ex10-17pg03.jpg GRAPHIC 124465
6 GRAPHIC ex10-17pg04.jpg GRAPHIC 117060
7 GRAPHIC ex10-17pg05.jpg GRAPHIC 113653
8 GRAPHIC ex10-17pg06.jpg GRAPHIC 89612
9 GRAPHIC ex10-17pg07.jpg GRAPHIC 58481
10 v216520_ex31-1.htm EX-31.1 15855
11 v216520_ex32-1.htm EX-32.1 7073
  Complete submission text file 0001144204-11-018135.txt   2505015
Mailing Address 1375 CALIFORNIA ROAD QUAKERTOWN PA 18951
Business Address 1375 CALIFORNIA ROAD QUAKERTOWN PA 18951 267-772-0107
SignPath Pharma, Inc. (Filer) CIK: 0001455694 (see all company filings)

EIN.: 205079533 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-158474 | Film No.: 11720543
SIC: 2834 Pharmaceutical Preparations